Literature DB >> 11260015

Bone marrow involvement in cutaneous mastocytosis.

L A Fearfield1, N Francis, K Henry, C Costello, C B Bunker.   

Abstract

BACKGROUND: Cutaneous mastocytosis is considered a relatively benign and indolent form of mast cell disease, which either ultimately regresses, remains stable or is only slowly progressive. Previously, it has been purported that no more than 60% of adult patients with cutaneous mastocytosis will have occult bone marrow involvement.
OBJECTIVES: To investigate the frequency of bone marrow involvement in patients with mastocytosis but without systemic symptoms.
METHODS: Bone marrow aspirate and trephine biopsy were performed in 13 consecutive patients with cutaneous mastocytosis attending our department.
RESULTS: All but one of these patients had evidence of bone marrow involvement. Bone marrow cytogenetic abnormalities have been found in patients with cutaneous mastocytosis: all our patients who were analysed showed a normal karyotype.
CONCLUSIONS: Bone marrow involvement is common in adults with cutaneous mastocytosis.

Entities:  

Mesh:

Year:  2001        PMID: 11260015     DOI: 10.1046/j.1365-2133.2001.04084.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability.

Authors:  Yasuko Furumoto; Nicolas Charles; Ana Olivera; Wai Hang Leung; Sandra Dillahunt; Jennifer L Sargent; Kevin Tinsley; Sandra Odom; Eric Scott; Todd M Wilson; Kamran Ghoreschi; Manfred Kneilling; Mei Chen; David M Lee; Silvia Bolland; Juan Rivera
Journal:  Blood       Date:  2011-09-16       Impact factor: 22.113

2.  Assessing quality of life in patients with mastocytosis: development of the disease-specific questionnaire.

Authors:  Natalia Spolak-Bobryk; Marek Niedoszytko; Ewa Jassem; Marta Chełmińska; Magdalena Lange; Mikołaj Majkowicz; Bogusław Nedoszytko; Judyta Borchet
Journal:  Postepy Dermatol Alergol       Date:  2022-01-11       Impact factor: 1.837

3.  Phenotypic and genotypic characteristics of mastocytosis according to the age of onset.

Authors:  Fanny Lanternier; Annick Cohen-Akenine; Fabienne Palmerini; Frédéric Feger; Ying Yang; Yael Zermati; Stéphane Barète; Beatrix Sans; Cédric Baude; David Ghez; Felipe Suarez; Richard Delarue; Philippe Casassus; Christine Bodemer; Adeline Catteau; Frédérique Soppelsa; Katia Hanssens; Michel Arock; Hagay Sobol; Sylvie Fraitag; Danièle Canioni; Alain Moussy; Jean Marie Launay; Patrice Dubreuil; Olivier Hermine; Olivier Lortholary
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.